P

Inventor

JONES PHILIP

US135 patents
⚠️ This page may combine multiple inventors who share the name “JONES PHILIP”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV TEXAS

17 patents
US10344025B2Jul 9, 2019

GLS1 inhibitors for treating disease

UNIV TEXAS12 citations91
US10280171B2May 7, 2019

Heterocyclic inhibitors of PTPN11

UNIV TEXAS24 citations91
US9809588B2Nov 7, 2017

GLS1 inhibitors for treating disease

UNIV TEXAS15 citations91
US11603365B2Mar 14, 2023

Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamide

UNIV TEXAS4 citations85
US11370786B2Jun 28, 2022

GLS1 inhibitors for treating disease

UNIV TEXAS6 citations84
US10899740B2Jan 26, 2021

Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido)pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide

UNIV TEXAS8 citations84
US10150753B2Dec 11, 2018

Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyrdin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide

UNIV TEXAS7 citations84
US10766892B2Sep 8, 2020

GLS1 inhibitors for treating disease

UNIV TEXAS9 citations83
US10738043B2Aug 11, 2020

GLS1 inhibitors for treating disease

UNIV TEXAS6 citations83
US10421765B2Sep 24, 2019

Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase

UNIV TEXAS7 citations82
US10392376B2Aug 27, 2019

Heterocyclic inhibitors of ATR kinase

UNIV TEXAS7 citations82
US9115120B2Aug 25, 2015

Heterocyclic modulators of HIF activity for treatment of disease

UNIV TEXAS9 citations82
US11400108B2Aug 2, 2022

Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling

UNIV TEXAS1 citations73
US10933078B2Mar 2, 2021

Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling

UNIV TEXAS2 citations73
US10363248B2Jul 30, 2019

Salts of heterocyclic modulators of HIF activity for treatment of disease

UNIV TEXAS2 citations73
US10093664B2Oct 9, 2018

Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease

UNIV TEXAS4 citations73
US12186324B2Jan 7, 2025

Imidazopiperazine inhibitors of transcription activating proteins

UNIV TEXAS3 citations72

MERCK SHARP & DOHME

5 patents

JONES PHILIP

3 patents

BOARD OF REGENTS UNIV OF TEXAS SYSTEM

3 patents

ANGELETTI P IST RICHERCHE BIO

3 patents

ULTRAHAPTICS IP LTD

2 patents

MOTOROLA INC

2 patents

NAVIRE PHARMA INC

2 patents

IBM

2 patents

BARDEN JULIAN ALEXANDER

1 patent

BOEING CO

1 patent

HILTI AG

1 patent

SUNOVION PHARMACEUTICALS INC

1 patent

BIOSCEPTRE AUST PTY LTD

1 patent

BIOSCEPTRE INT LTD

1 patent

LUSCHI CARLO

1 patent

CAMPBELL JOHN EMMERSON

1 patent

BRANCA DANILA

1 patent

INST APPLIED CANCER SCIENCE THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CT

1 patent

PITCRAFT SUMMIT LTD

1 patent

Showing the top 50 of 135 patents by PatentIndex Score.